- In February 2023, Siemens Healthineers announced a global OEM agreement with Sysmex Corporation focused on hemostasis products. This collaboration allows companies to supply diagnostic products for blood clotting disorders and anticoagulant therapy monitoring under their respective brands. With over 25 years of partnership, the agreement aims to enhance its extensive hemostasis product portfolios, addressing the growing demand for diverse testing solutions. Both companies are committed to improving access to effective hemostasis testing worldwide, ultimately benefiting patient outcomes.
